COIOSDeep risk insights through multi-disciplinary research across the globe
A car drives down a rural road past fields
Item refines Peer-reviewed Added

PALB2 carriers found by exome sequencing have raised cancer risk and higher mortality

In two population cohorts, exome-identified PALB2 carriers had raised cancer risk and mortality, though below family-based estimates.

This case-control study examined cancer risk in carriers of pathogenic or likely pathogenic PALB2 variants found by exome sequencing. It used UK Biobank (469,580 adults) and Geisinger MyCode (167,050), with cancers and deaths from linked registry and health records. Carrier prevalence was 1 in 940 in MyCode and 1 in 571 in UK Biobank, raised by a founder variant. Carriers had raised odds of pancreatic cancer and hazard ratios of 1.7 to 3.6 for any and female breast cancer. All-cause mortality was raised (hazard ratio 1.61 to 1.67), and survival after a cancer diagnosis was lower. These risks were lower than estimates from people ascertained through a personal or family history of cancer.

Why it is interesting: Most PALB2 risk estimates come from people ascertained through a personal or family history of cancer. Sequencing whole population cohorts gives lower but still raised cancer risks and higher mortality.

Source
JNCI: Journal of the National Cancer Institute, 18 November 2026
DOI
10.1093/jnci/djag429
Type
Peer-reviewed article
Design
Case-control and survival analysis in two population cohorts with exome sequencing linked to registry/EHR data (UK Biobank n=469,580; Geisinger MyCode n=167,050)
Verdict
Refines prior evidence
Driver
Cancer
Driver
What linked data reveals

Other drivers in Health today